Literature DB >> 24954463

Hospital-level variation in use of cardiovascular testing for adults with incident heart failure: findings from the cardiovascular research network heart failure study.

Steven A Farmer1, Justin Lenzo2, David J Magid3, Jerry H Gurwitz4, David H Smith5, Grace Hsu6, Sue Hee Sung6, Alan S Go7.   

Abstract

OBJECTIVES: This study aimed to characterize the use of cardiovascular testing for patients with incident heart failure (HF) hospitalization who participated in the National Heart, Lung, and Blood Institute sponsored Cardiovascular Research Network (CVRN) Heart Failure study.
BACKGROUND: HF is a common cause of hospitalization, and testing and treatment patterns may differ substantially between providers. Testing choices have important implications for the cost and quality of care.
METHODS: Crude and adjusted cardiovascular testing rates were calculated for each participating hospital. Cox proportional hazards regression models were used to examine hospital testing rates after adjustment for hospital-level patient case mix.
RESULTS: Of the 37,099 patients in the CVRN Heart Failure study, 5,878 patients were hospitalized with incident HF between 2005 and 2008. Of these, evidence of cardiovascular testing was available for 4,650 (79.1%) patients between 14 days before the incident HF admission and ending 6 months after the incident discharge. We compared crude and adjusted cardiovascular testing rates at the hospital level because the majority of testing occurred during the incident HF hospitalization. Of patients who underwent testing, 4,085 (87.9%) had an echocardiogram, 4,345 (93.4%) had a systolic function assessment, and 1,714 (36.9%) had a coronary artery disease assessment. Crude and adjusted testing rates varied markedly across the profiled hospitals, for individual testing modalities (e.g., echocardiography, stress echocardiography, nuclear stress testing, and left heart catheterization) and for specific clinical indications (e.g., systolic function assessment and coronary artery disease assessment).
CONCLUSIONS: For patients with newly diagnosed HF, we did not observe widespread overuse of cardiovascular testing in the 6 months following incident HF hospitalization relative to existing HF guidelines. Variations in testing were greatest for assessment of ischemia, in which testing guidelines are less certain.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular testing; geographic variations; heart failure

Mesh:

Year:  2014        PMID: 24954463      PMCID: PMC4104144          DOI: 10.1016/j.jcmg.2014.02.008

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  34 in total

1.  Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction.

Authors:  M A Quiñones; B H Greenberg; H A Kopelen; C Koilpillai; M C Limacher; D M Shindler; B J Shelton; D H Weiner
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

2.  2009 ASNC keynote lecture: measuring cost, cost-effectiveness, and quality in cardiovascular imaging.

Authors:  Robert O Bonow
Journal:  J Nucl Cardiol       Date:  2010-06       Impact factor: 5.952

3.  The natural history of congestive heart failure: the Framingham study.

Authors:  P A McKee; W P Castelli; P M McNamara; W B Kannel
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

4.  Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.

Authors:  Daniela Cardinale; Alessandro Colombo; Giuseppina Lamantia; Nicola Colombo; Maurizio Civelli; Gaia De Giacomi; Mara Rubino; Fabrizio Veglia; Cesare Fiorentini; Carlo M Cipolla
Journal:  J Am Coll Cardiol       Date:  2010-01-19       Impact factor: 24.094

Review 5.  Cardiovascular imaging research at the crossroads.

Authors:  Leslee J Shaw; James K Min; Rory Hachamovitch; Eric D Peterson; Robert C Hendel; Pamela K Woodard; Daniel S Berman; Pamela S Douglas
Journal:  JACC Cardiovasc Imaging       Date:  2010-03

6.  Process of care performance measures and long-term outcomes in patients hospitalized with heart failure.

Authors:  Mark E Patterson; Adrian F Hernandez; Bradley G Hammill; Gregg C Fonarow; Eric D Peterson; Kevin A Schulman; Lesley H Curtis
Journal:  Med Care       Date:  2010-03       Impact factor: 2.983

7.  Recent national trends in readmission rates after heart failure hospitalization.

Authors:  Joseph S Ross; Jersey Chen; Zhenqiu Lin; Héctor Bueno; Jeptha P Curtis; Patricia S Keenan; Sharon-Lise T Normand; Geoffrey Schreiner; John A Spertus; Maria T Vidán; Yongfei Wang; Yun Wang; Harlan M Krumholz
Journal:  Circ Heart Fail       Date:  2009-11-10       Impact factor: 8.790

8.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

9.  The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure.

Authors:  Jeptha P Curtis; Seth I Sokol; Yongfei Wang; Saif S Rathore; Dennis T Ko; Farid Jadbabaie; Edward L Portnay; Stephen J Marshalko; Martha J Radford; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

10.  The diagnosis of heart failure in primary care: value of symptoms and signs.

Authors:  Cândida Fonseca; Humberto Morais; Teresa Mota; Fernando Matias; Catarina Costa; António Gouveia-Oliveira; Fátima Ceia
Journal:  Eur J Heart Fail       Date:  2004-10       Impact factor: 15.534

View more
  11 in total

1.  Volume to Value: Defining the Value of Cardiovascular Imaging.

Authors:  Sangeeta B Shah; Tripti Gupta; Kyle D Severinsen; Elizabeth McIlwain; Christopher J White
Journal:  Ochsner J       Date:  2016

2.  Incident anaemia in older adults with heart failure: rate, aetiology, and association with outcomes.

Authors:  Andrew P Ambrosy; Jerry H Gurwitz; Grace H Tabada; Andrew Artz; Stanley Schrier; Sunil V Rao; Huiman X Barnhart; Kristi Reynolds; David H Smith; Pamela N Peterson; Sue Hee Sung; Harvey Jay Cohen; Alan S Go
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2019-10-01

3.  Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.

Authors:  Jimmy Zheng; Paul A Heidenreich; Shun Kohsaka; William F Fearon; Alexander T Sandhu
Journal:  J Am Coll Cardiol       Date:  2022-03-08       Impact factor: 27.203

Review 4.  Left Main Coronary Artery Disease in Diabetics: Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting?

Authors:  Logan Disney; Chandrashekhar Ramaiah; Meghna Ramaiah; Suresh Keshavamurthy
Journal:  Int J Angiol       Date:  2021-08-31

5.  Variation in use of echocardiography among veterans who use the Veterans Health Administration vs Medicare.

Authors:  Vinay Kini; Fenton H McCarthy; Sheeva Rajaei; Andrew J Epstein; Paul A Heidenreich; Peter W Groeneveld
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

6.  Association of Ischemic Evaluation and Clinical Outcomes Among Patients Admitted With New-Onset Heart Failure.

Authors:  Erin McGuinn; Theodore Warsavage; Mary E Plomondon; Javier A Valle; P Michael Ho; Stephen W Waldo
Journal:  J Am Heart Assoc       Date:  2021-02-15       Impact factor: 5.501

7.  Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.

Authors:  Ajay J Kirtane; Darshan Doshi; Martin B Leon; John M Lasala; E Magnus Ohman; William W O'Neill; Adhir Shroff; Mauricio G Cohen; Igor F Palacios; Nirat Beohar; Nir Uriel; Navin K Kapur; Dimitri Karmpaliotis; William Lombardi; George D Dangas; Manish A Parikh; Gregg W Stone; Jeffrey W Moses
Journal:  Circulation       Date:  2016-08-02       Impact factor: 39.918

8.  Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.

Authors:  Darshan Doshi; Ori Ben-Yehuda; Machaon Bonafede; Noam Josephy; Dimitri Karmpaliotis; Manish A Parikh; Jeffrey W Moses; Gregg W Stone; Martin B Leon; Allan Schwartz; Ajay J Kirtane
Journal:  J Am Coll Cardiol       Date:  2016-08-02       Impact factor: 27.203

9.  Trends in High- and Low-Value Cardiovascular Diagnostic Testing in Fee-for-Service Medicare, 2000-2016.

Authors:  Vinay Kini; Timea Viragh; David Magid; Frederick A Masoudi; Ali Moghtaderi; Bernard Black
Journal:  JAMA Netw Open       Date:  2019-10-02

10.  Differences in High- and Low-Value Cardiovascular Testing by Health Insurance Provider.

Authors:  Vinay Kini; Bridget Mosley; Sridharan Raghavan; Prateeti Khazanie; Steven M Bradley; David J Magid; P Michael Ho; Frederick A Masoudi
Journal:  J Am Heart Assoc       Date:  2021-01-28       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.